关于神经囊虫病管理中争议的起源和演变的个人叙述。
A Personal Account Regarding the Origin and Evolution of Controversies in the Management of Neurocysticercosis.
机构信息
School of Medicine, Universidad Espíritu Santo-Ecuador, Guayaquil, Ecuador.
出版信息
Am J Trop Med Hyg. 2019 Apr;100(4):780-782. doi: 10.4269/ajtmh.18-0921.
Abstract
A panel of experts from the Infectious Disease Society of America and The American Society of Tropical Medicine and Hygiene recently published guidelines for management of neurocysticercosis, showing that clinical manifestations as well as the stage of involution and the anatomical location of parasites must be taken into account before the start of a rational therapy. Soon thereafter, isolated opinions attempted to discredit these guidelines, arguing insufficient or inadequate evidence and suggesting that they should not be followed worldwide. In view of these conflicting reports, it is appropriate to review the origin and evolution of the controversy on the medical treatment of neurocysticercosis.
摘要
美国传染病学会和美国热带医学与卫生学会的专家组最近发布了关于神经囊虫病管理的指南，指出在开始合理治疗之前，必须考虑临床表现以及寄生虫的退化阶段和解剖位置。此后不久，一些孤立的意见试图诋毁这些指南，认为其证据不足或不充分，并建议不应在全球范围内遵循这些指南。鉴于这些相互矛盾的报告，有必要回顾一下关于神经囊虫病治疗的争议的起源和演变。
相似文献
1
A Personal Account Regarding the Origin and Evolution of Controversies in the Management of Neurocysticercosis.关于神经囊虫病管理中争议的起源和演变的个人叙述。
Am J Trop Med Hyg. 2019 Apr;100(4):780-782. doi: 10.4269/ajtmh.18-0921.
2
Evolution of concepts in the management of cysticercosis of the brain: Then (1970) and now (2018).脑囊尾蚴病治疗理念的演变：过去（1970年）与现在（2018年）。
Neurol India. 2018 Jul-Aug;66(4):919-927. doi: 10.4103/0028-3886.236969.
3
Diagnosis and Treatment of Neurocysticercosis: 2017 Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH).神经囊尾蚴病的诊断与治疗：美国感染病学会（IDSA）和美国热带医学与卫生学会（ASTMH）2017年临床实践指南。
Clin Infect Dis. 2018 Apr 3;66(8):1159-1163. doi: 10.1093/cid/ciy157.
4
Diagnosis and Treatment of Neurocysticercosis: 2017 Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH).神经囊尾蚴病的诊断与治疗：美国传染病学会（IDSA）和美国热带医学与卫生学会（ASTMH）2017年临床实践指南。
Am J Trop Med Hyg. 2018 Apr;98(4):945-966. doi: 10.4269/ajtmh.18-88751.
5
New guidelines for the diagnosis and treatment of neurocysticercosis: a difficult proposal for patients in endemic countries.《神经囊尾蚴病诊断和治疗指南》：对流行国家患者来说是一项艰难的提议。
Expert Rev Neurother. 2018 Oct;18(10):743-747. doi: 10.1080/14737175.2018.1518133. Epub 2018 Sep 6.
6
Diagnosis and Treatment of Neurocysticercosis: 2017 Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH).神经囊尾蚴病的诊断与治疗：美国传染病学会（IDSA）和美国热带医学与卫生学会（ASTMH）2017年临床实践指南。
Clin Infect Dis. 2018 Apr 3;66(8):e49-e75. doi: 10.1093/cid/cix1084.
7
Neurocysticercosis: an update on diagnosis, treatment, and prevention.神经囊尾蚴病：诊断、治疗和预防的最新进展。
Curr Opin Infect Dis. 2022 Jun 1;35(3):246-254. doi: 10.1097/QCO.0000000000000831.
8
Management of neurocysticercosis.神经囊尾蚴病的管理
CNS Drugs. 2003;17(8):577-91. doi: 10.2165/00023210-200317080-00003.
9
Evaluating Healthcare Claims for Neurocysticercosis by Using All-Payer All-Claims Data, Oregon, 2010-2013.2010 - 2013年，俄勒冈州利用全支付方全索赔数据评估神经囊尾蚴病的医疗保健索赔情况。
Emerg Infect Dis. 2016 Dec;22(12):2168-2170. doi: 10.3201/eid2212.160370.
10
Updates on the management of neurocysticercosis.神经囊虫病管理的最新进展。
Curr Opin Infect Dis. 2018 Oct;31(5):377-382. doi: 10.1097/QCO.0000000000000480.
引用本文的文献
1
Human Neurocysticercosis: An Overview.人类神经囊尾蚴病：概述
Pathogens. 2022 Oct 20;11(10):1212. doi: 10.3390/pathogens11101212.
2
Evaluating the Association of Calcified Neurocysticercosis and Mesial Temporal Lobe Epilepsy With Hippocampal Sclerosis in a Large Cohort of Patients With Epilepsy.在一大群癫痫患者中评估钙化性神经囊尾蚴病和内侧颞叶癫痫与海马硬化的关联。
Front Neurol. 2022 Jan 27;12:769356. doi: 10.3389/fneur.2021.769356. eCollection 2021.
3
Parasitic Infections of the Nervous System.神经系统寄生虫感染。
Continuum (Minneap Minn). 2021 Aug 1;27(4):943-962. doi: 10.1212/CON.0000000000000986.
4
Neurocysticercosis. A frequent cause of seizures, epilepsy, and other neurological morbidity in most of the world.脑囊虫病。在世界上大多数地区，它是导致癫痫发作、癫痫和其他神经疾病的常见原因。
J Neurol Sci. 2021 Aug 15;427:117527. doi: 10.1016/j.jns.2021.117527. Epub 2021 Jun 17.
5
Taenia solium Cysticercosis and Its Impact in Neurological Disease.猪带绦虫囊尾蚴病及其在神经疾病中的影响。
Clin Microbiol Rev. 2020 May 27;33(3). doi: 10.1128/CMR.00085-19. Print 2020 Jun 17.
本文引用的文献
1
New guidelines for the diagnosis and treatment of neurocysticercosis: a difficult proposal for patients in endemic countries.《神经囊尾蚴病诊断和治疗指南》：对流行国家患者来说是一项艰难的提议。
Expert Rev Neurother. 2018 Oct;18(10):743-747. doi: 10.1080/14737175.2018.1518133. Epub 2018 Sep 6.
2
Diagnosis and Treatment of Neurocysticercosis: 2017 Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH).神经囊尾蚴病的诊断与治疗：美国传染病学会（IDSA）和美国热带医学与卫生学会（ASTMH）2017年临床实践指南。
Am J Trop Med Hyg. 2018 Apr;98(4):945-966. doi: 10.4269/ajtmh.18-88751.
3
Diagnosis and Treatment of Neurocysticercosis: 2017 Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH).神经囊尾蚴病的诊断与治疗：美国感染病学会（IDSA）和美国热带医学与卫生学会（ASTMH）2017年临床实践指南。
Clin Infect Dis. 2018 Apr 3;66(8):1159-1163. doi: 10.1093/cid/ciy157.
4
Albendazole and Corticosteroids for the Treatment of Solitary Cysticercus Granuloma: A Network Meta-analysis.阿苯达唑和皮质类固醇治疗孤立性囊尾蚴肉芽肿：一项网状Meta分析
PLoS Negl Trop Dis. 2016 Feb 5;10(2):e0004418. doi: 10.1371/journal.pntd.0004418. eCollection 2016 Feb.
5
The effect of albendazole treatment on seizure outcomes in patients with symptomatic neurocysticercosis.阿苯达唑治疗对症状性神经囊尾蚴病患者癫痫发作转归的影响。
Trans R Soc Trop Med Hyg. 2015 Nov;109(11):738-46. doi: 10.1093/trstmh/trv078. Epub 2015 Oct 3.
6
Evidence-based guideline: treatment of parenchymal neurocysticercosis: report of the Guideline Development Subcommittee of the American Academy of Neurology.循证指南：实质型神经囊虫病的治疗：美国神经病学学会指南制定小组委员会的报告。
Neurology. 2013 Apr 9;80(15):1424-9. doi: 10.1212/WNL.0b013e31828c2f3e.
7
Drug therapy for solitary cysticercus granuloma: a systematic review and meta-analysis.药物治疗孤立性囊尾蚴肉芽肿：系统评价和荟萃分析。
Neurology. 2013 Jan 8;80(2):152-62. doi: 10.1212/WNL.0b013e31827b90a8. Epub 2012 Dec 26.
8
Effects of albendazole treatment on neurocysticercosis: a randomised controlled trial.阿苯达唑治疗神经囊尾蚴病的效果：一项随机对照试验。
J Neurol Neurosurg Psychiatry. 2008 Sep;79(9):1050-5. doi: 10.1136/jnnp.2008.144899. Epub 2008 May 21.
9
Does albendazole affect seizure remission and computed tomography response in children with neurocysticercosis? A Systematic review and meta-analysis.阿苯达唑对神经囊尾蚴病患儿的癫痫缓解及计算机断层扫描反应有影响吗？一项系统评价和荟萃分析。
J Child Neurol. 2007 Feb;22(2):135-42. doi: 10.1177/0883073807300295.
10
Meta-analysis: Cysticidal drugs for neurocysticercosis: albendazole and praziquantel.荟萃分析：用于神经囊尾蚴病的杀囊药物：阿苯达唑和吡喹酮。
Ann Intern Med. 2006 Jul 4;145(1):43-51. doi: 10.7326/0003-4819-145-1-200607040-00009.
Zotero 插件